CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $397,626 | +38.1% | 11,719 | +81.5% | 0.00% | 0.0% |
| Q4 2022 | $287,833 | -91.0% | 6,458 | -94.5% | 0.00% | -94.4% |
| Q2 2022 | $3,190,000 | +300.8% | 118,345 | +474.4% | 0.02% | +800.0% |
| Q4 2021 | $796,000 | +47.4% | 20,604 | +106.1% | 0.00% | 0.0% |
| Q3 2021 | $540,000 | -41.7% | 9,999 | -77.8% | 0.00% | -60.0% |
| Q1 2021 | $927,000 | -53.9% | 44,995 | -60.8% | 0.01% | -66.7% |
| Q4 2020 | $2,011,000 | +306.3% | 114,764 | +243.8% | 0.02% | +114.3% |
| Q3 2020 | $495,000 | +725.0% | 33,382 | +175.2% | 0.01% | +600.0% |
| Q1 2019 | $60,000 | – | 12,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |